DR. CHRISTOPHER P DAVOLOS OD
Prescription History 1013961663
Optometrist in Wilmington, DE
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. CHRISTOPHER P DAVOLOS OD, an active Optometrist specialist practicing in Wilmington, DE. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 362 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 93 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other DE PrescribersVs. DE Avg |
|---|---|---|---|
| Latanoprost | 93 | $13.10▼ below DE avg | ▼ Less than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2024, this provider wrote 93 Medicare prescriptions for Latanoprost, about 69% of the volume of the typical Delaware prescriber of this medication (134.5). Medicare paid an average of $13.10 per fill, versus $15.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 163.3 30-Day Fills standardized to 30-day supplies 4,763 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 46 | $17.49▼ below DE avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 46 Medicare prescriptions for Dorzolamide-Timolol, about half the volume of the typical Delaware prescriber of this medication (80.2). Medicare paid an average of $17.49 per fill, versus $18.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 97.6 30-Day Fills standardized to 30-day supplies 2,929 Days of Medication total across all patients in 2024 | |||
| ErythromycinErythromycin Base | 40 | $10.20▼ below DE avg | ≈ Typical |
About Erythromycin: This medication is used to treat certain eye infections (such as conjunctivitis). Show more ▾ It is also used to prevent certain eye infections in newborns. It belongs to a class of drugs known as macrolide antibiotics. Erythromycin works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. In 2024, this provider wrote 40 Medicare prescriptions for Erythromycin, about the same volume as the typical Delaware prescriber of this medication (42.7). Medicare paid an average of $10.20 per fill, versus $11.25 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 40 30-Day Fills standardized to 30-day supplies 468 Days of Medication total across all patients in 2024 | |||
| Timolol Maleate | 37 | $26.00 | ▼ Less than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2024, this provider wrote 37 Medicare prescriptions for Timolol Maleate, about half the volume of the typical Delaware prescriber of this medication (69). Medicare paid an average of $26.00 per fill, versus $19.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 57.5 30-Day Fills standardized to 30-day supplies 1,658 Days of Medication total across all patients in 2024 | |||
| LumiganBimatoprost | 31 | $344.93▼ below DE avg | ≈ Typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 31 Medicare prescriptions for Lumigan, about 76% of the volume of the typical Delaware prescriber of this medication (40.5). Medicare paid an average of $344.93 per fill, versus $577.87 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 47.2 30-Day Fills standardized to 30-day supplies 1,400 Days of Medication total across all patients in 2024 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 31 | $11.57 | ≈ Typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2024, this provider wrote 31 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about 82% of the volume of the typical Delaware prescriber of this medication (37.7). Medicare paid an average of $11.57 per fill, versus $10.54 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32.3 30-Day Fills standardized to 30-day supplies 394 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 27 | $211.91▼ below DE avg | ≈ Typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. In 2024, this provider wrote 27 Medicare prescriptions for Brimonidine Tartrate-Timolol, about the same volume as the typical Delaware prescriber of this medication (27.6). Medicare paid an average of $211.91 per fill, versus $216.11 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 51.7 30-Day Fills standardized to 30-day supplies 1,441 Days of Medication total across all patients in 2024 | |||
| XiidraLifitegrast | 17 | $1,899.35 | ▼ Less than typical |
About Xiidra: This medication is used to treat dry eye disease. Show more ▾ An LFA-1 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1) antagonist that is used in the treatment of DRY EYE SYNDROMES. In 2024, this provider wrote 17 Medicare prescriptions for Xiidra, about half the volume of the typical Delaware prescriber of this medication (29.9). Medicare paid an average of $1,899.35 per fill, versus $1,253.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 49 30-Day Fills standardized to 30-day supplies 1,470 Days of Medication total across all patients in 2024 | |||
| Cyclosporine | 16 | $441.07▼ below DE avg | ≈ Typical |
About Cyclosporine: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 16 Medicare prescriptions for Cyclosporine, about 83% of the volume of the typical Delaware prescriber of this medication (19.3). Medicare paid an average of $441.07 per fill, versus $487.95 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 18 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2024 | |||
| CombiganBrimonidine Tartrate/Timolol | 12 | $729.44 | ▼ Less than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2024, this provider wrote 12 Medicare prescriptions for Combigan, about half the volume of the typical Delaware prescriber of this medication (22.1). Medicare paid an average of $729.44 per fill, versus $496.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20.3 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2024 | |||
| Doxycycline Hyclate | 12 | $35.84 | ▼ Less than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 12 Medicare prescriptions for Doxycycline Hyclate, about a third of the volume of the typical Delaware prescriber of this medication (31.7). Medicare paid an average of $35.84 per fill, versus $12.83 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19.5 30-Day Fills standardized to 30-day supplies 585 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. CHRISTOPHER P DAVOLOS OD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Wilmington, DE practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among DE prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
